Amdocs Valuation
| AOS Stock | EUR 64.80 3.30 4.85% |
At this time, the firm appears to be fairly valued. Amdocs Limited shows a prevailing Real Value of €66.54 per share. The current price of the firm is €64.8. Our model approximates the value of Amdocs Limited from analyzing the firm fundamentals such as profit margin of 0.12 %, and Return On Equity of 0.16 as well as examining its technical indicators and probability of bankruptcy.
Price Book 2.545 | Enterprise Value 7.8 B | Enterprise Value Ebitda 9.9305 | Price Sales 1.5742 | Forward PE 10.7411 |
Fairly Valued
Today
Please note that Amdocs' price fluctuation is very steady at this time. Calculation of the real value of Amdocs Limited is based on 3 months time horizon. Increasing Amdocs' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Amdocs stock is determined by what a typical buyer is willing to pay for full or partial control of Amdocs Limited. Since Amdocs is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Amdocs Stock. However, Amdocs' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 64.8 | Real 66.54 | Hype 64.79 | Naive 63.21 |
The real value of Amdocs Stock, also known as its intrinsic value, is the underlying worth of Amdocs Limited Company, which is reflected in its stock price. It is based on Amdocs' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Amdocs' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Amdocs Limited helps investors to forecast how Amdocs stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Amdocs more accurately as focusing exclusively on Amdocs' fundamentals will not take into account other important factors: Amdocs Cash |
|
About Amdocs Valuation
The stock valuation mechanism determines Amdocs' current worth on a weekly basis. Our valuation model uses a comparative analysis of Amdocs. We calculate exposure to Amdocs's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Amdocs's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2 B | 1.6 B |
Amdocs Quarterly Retained Earnings |
|
Complementary Tools for Amdocs Stock analysis
When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |